KRAS can regulate cell growth, differentiation and apoptosis, its mutations mainly occur at codons 12 and 13, and have been found approximately in 20-30% of NSCLC tumor samples (109). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.